0
0.5
1
1.5
2+
Discharge at day 14, 24mg
62%
Improvement
Relative Risk
Discharge at day 14, 12mg
44%
Clinical worsening, 24mg
32%
Clinical worsening, 12mg
55%
Viral clearance, 24mg, d..
24%
primary
Viral clearance, 12mg, d..
6%
Viral clearance, 24m.. (b)
10%
Viral clearance, 12m.. (b)
-3%
Ivermectin RIVET-COV EARLY TREATMENT DB RCT
Is early treatment with ivermectin beneficial for COVID-19?
Double-blind RCT 157 patients in India (July - September 2020)
Improved recovery (p=0.27) and viral clearance (p=0.18), not sig.
c19ivm.org
Mohan et al., J. Infection and Chemoth.., Feb 2021
Favors ivermectin
Favors control